Statistics for Evaluating the extent of reusability of CYP2C19 genotype data among patients genotyped for antiplatelet therapy selection
Total visits
views | |
---|---|
Evaluating the extent of reusability of CYP2C19 genotype data among patients genotyped for antiplatelet therapy selection | 69 |
Total visits per month
views | |
---|---|
December 2024 | 0 |
January 2025 | 0 |
February 2025 | 0 |
March 2025 | 0 |
April 2025 | 0 |
May 2025 | 0 |
June 2025 | 0 |
File Visits
views | |
---|---|
java.util.UUID:83eb28fe-2123-4c32-9ce9-af265a3f07bb | 65 |
Beitelshees2020Evaluating-NIHAAM.pdf | 59 |
java.util.UUID:61fe9ef1-631a-49fe-a67d-feade171dfdd | 25 |
java.util.UUID:ed25a7fa-f423-440f-8a7e-3cec78a5f740 | 5 |
Top country views
views | |
---|---|
United States | 61 |
Canada | 1 |
Malaysia | 1 |
Top city views
views | |
---|---|
Wilmington | 42 |
Fairfield | 3 |
White Plains | 3 |
Houston | 2 |
Ann Arbor | 1 |
Cambridge | 1 |
Kuala Lumpur | 1 |
Mount Laurel | 1 |
Washington | 1 |
Winnipeg | 1 |